Brain Cognition and Memory Daily Support
Natural health product licensed in Canada
- Other names
- Brain Health Solution
- Licence holder
- Red Maple Bio Inc.
- NPN or DIN-HM
- 80103684
- Status
- Active licence
- Licence date
- 25 August 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 8 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 60 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Pyridoxamine | 4 mg | 8,000 µg |
| Sélénium Source : Sélénate de sodium | 30 mcg | 60 µg |
| Piper nigrum Source : Fruit Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 75 mg Potency : 90 % Piperine | 2.5 mg | Not calculated |
| Niacine Source : Niacinamide | 8 mg | Not calculated |
| Vitamine B12 Source : Hydroxocobalamine | 4 mcg | 8 µg |
| Vitamine D Source : Cholécalciférol | 12.5 mcg | 25 µg |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 25 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,250 mg Potency : 6 % Terpene lactones | 25 mg | Not calculated |
| Bacopa monnieri Source : Sommité Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 3,000 mg Potency : 40 % Bacosides | 150 mg | Not calculated |
| Rhodiola rosea Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg Potency : 1 % Salidroside | 50 mg | Not calculated |
| L-théanine Source : L-Théanine | 25 mg | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps support cognitive health and/or brain function. Helps support memory. Helps to maintain immune function. Source of vitamins and a mineral, factors in the maintenance of good health and in normal growth and development. Source of antioxidant that helps to protect cell against the oxidative damage caused by free radicals. Helps to temporarily promote relaxation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you are taking health products that affect blood coagulation as this may increase the risk of spontaneous bleeding. Do not use this product if you have bipolar disorder or bipolar spectrum disorder .
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction, or if you have stomach ulcers or excess stomach acid. Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure or seizures. Consult a health care practitioner prior to use if you are taking any other medications or natural health products, as black pepper/piperine may alter their effectiveness. Consult a health care practitioner prior to use if you are taking antidepressant medication, hormone replacement therapy (HRT) or birth control pills.
Source
Official Health Canada record, licence 80103684
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.